Detail page

Knowledge Web

Person

Jürgen Flöge (1959-)

Arzt

Name	Jürgen Flöge
Time	1959- (Date of birth and death)
Place	Aachen (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med. Dr. med.
Profession	Arzt (characteristic profession) Internist Nephrologe
Variant	Jürgen Floege J. Floege
Related	Klinik für Nieren- und Hochdruckkrankheiten, Rheumatologische und Immunologische Erkrankungen (Med. Klinik II)
Further information	tätig an der Medizinischen Klinik II (Nephrologie), Universitätsklinikum der RWTH Aachen
Source	Internet
Record type	Person
GND-Identifier	110658205
Record ID	110658205
Involved in show all Praxistipps zur Systematisierung des Impfmanagements Die 4 P für Versorgungssicherheit in der Nephrologie : Strategien gegen den demografischen Doppelschlag Wege für bessere Impfraten : Indikationsimpfungen bei Erwachsenen Quo Vadis Standardization of Anti-Nephrin Antibody Detection? Platelet-derived growth factor-C contributes to kidney inflammation in experimental hypertension with little effect on the peritubular capillary network Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy Treatment of patients with IgA nephropathy: a call for a new paradigm Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor Vitamin K preserves gamma-glutamyl carboxylase activity against carbamylations in uremia: Implications for vascular calcification and adjunct therapies Wege für bessere Impfraten : Indikationsimpfungen bei Erwachsenen Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study IgA-Nephropathie Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning Grundlagenwissenschaftler im medizinischen Forschungsumfeld in Deutschland : Ein Best-Practice-Ausbildungsmodell aus der kardiorenalen Forschung Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial Perihilar FSGS lesions originate from flat parietal epithelial cells Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy A simple clinical score to reduce unnecessary testing for Puumala hantavirus Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney International 2024;105(3):447–449 Corrigendum to “KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis.” Kidney International 2024;105(3S):S71–S116 Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis Executive summary of the KDIGO 2024 clinical practice guideline for the management of Lupus Nephritis Grundlagenwissenschaftler im medizinischen Forschungsumfeld in Deutschland : Ein Best-Practice-Ausbildungsmodell aus der kardiorenalen Forschung Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health Interactive exploration of adverse events and multimorbidity in CKD KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury Long term outcomes of patients with IgA nephropathy in the German CKD (GCKD) cohort Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort Long-term outcomes of patients with IgA nephropathy in the German CKD cohort Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group Moderator's view: after SGLT2i and MRA antagonists, where do we go? Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study Perihilar FSGS lesions originate from flat parietal epithelial cells Physical exercise in haemodialysis patients: which type of exercise is more convenient? Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy The Costs of Anonymization: Case Study Using Clinical Data The role of desmoglein-2 in kidney disease The time is now: CKJ adopts new policies for patient representation and for more sex-inclusive research Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern und chronischer Nierenerkrankung : Leitlinienempfehlungen, Datenlage zu oralen Antikoagulanzien bei CKD, Studien zum Vorhofverschluss Herz und Niere Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort Seltene glomeruläre Erkrankungen Progressionshemmung bei chronischen Nierenerkrankungen A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study Corrigendum to “International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology.” Kidney International, 2023;104:36–45 Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy IgA nephropathy : the lectin pathway and implications for targeted therapy Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species Magnesium Improves Cardiac Function in Experimental Uremia by Altering Cardiac Elastin Protein Content

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jürgen Flöge (1959-)

Praxistipps zur Systematisierung des Impfmanagements

Die 4 P für Versorgungssicherheit in der Nephrologie : Strategien gegen den demografischen Doppelschlag

Wege für bessere Impfraten : Indikationsimpfungen bei Erwachsenen

Quo Vadis Standardization of Anti-Nephrin Antibody Detection?

Platelet-derived growth factor-C contributes to kidney inflammation in experimental hypertension with little effect on the peritubular capillary network

Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy

Treatment of patients with IgA nephropathy: a call for a new paradigm

Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor

Vitamin K preserves gamma-glutamyl carboxylase activity against carbamylations in uremia: Implications for vascular calcification and adjunct therapies

Wege für bessere Impfraten : Indikationsimpfungen bei Erwachsenen

Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study

IgA-Nephropathie

Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning

Grundlagenwissenschaftler im medizinischen Forschungsumfeld in Deutschland : Ein Best-Practice-Ausbildungsmodell aus der kardiorenalen Forschung

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial

Perihilar FSGS lesions originate from flat parietal epithelial cells

Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy

A simple clinical score to reduce unnecessary testing for Puumala hantavirus

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial

Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney International 2024;105(3):447–449

Corrigendum to “KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis.” Kidney International 2024;105(3S):S71–S116

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis

Executive summary of the KDIGO 2024 clinical practice guideline for the management of Lupus Nephritis

Grundlagenwissenschaftler im medizinischen Forschungsumfeld in Deutschland : Ein Best-Practice-Ausbildungsmodell aus der kardiorenalen Forschung

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health

Interactive exploration of adverse events and multimorbidity in CKD

KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS

Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury

Long term outcomes of patients with IgA nephropathy in the German CKD (GCKD) cohort

Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort

Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort

Long-term outcomes of patients with IgA nephropathy in the German CKD cohort

Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

Moderator's view: after SGLT2i and MRA antagonists, where do we go?

Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study

Perihilar FSGS lesions originate from flat parietal epithelial cells

Physical exercise in haemodialysis patients: which type of exercise is more convenient?

Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy

Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy

The Costs of Anonymization: Case Study Using Clinical Data

The role of desmoglein-2 in kidney disease

The time is now: CKJ adopts new policies for patient representation and for more sex-inclusive research

Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern und chronischer Nierenerkrankung : Leitlinienempfehlungen, Datenlage zu oralen Antikoagulanzien bei CKD, Studien zum Vorhofverschluss

Herz und Niere

Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort

Seltene glomeruläre Erkrankungen

Progressionshemmung bei chronischen Nierenerkrankungen

A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program

Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study

Corrigendum to “International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology.” Kidney International, 2023;104:36–45

Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease

Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy

IgA nephropathy : the lectin pathway and implications for targeted therapy

Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species

Magnesium Improves Cardiac Function in Experimental Uremia by Altering Cardiac Elastin Protein Content